Skip to main content
. Author manuscript; available in PMC: 2019 Jun 23.
Published in final edited form as: J Pediatr Hematol Oncol. 2015 Apr;37(3):185–189. doi: 10.1097/MPH.0000000000000214

Table 1.

Demographics

Normal QST (n=35) Abnormal QST (n=13)
Age 13.9 ±1.9 12.8 ±1.9
Gender
 Females 16 (45.7%) 6 (46.2%)
 Males 19 (54.3%) 7 (53.8%)
Hgb Genotype
 Hgb SS 18 (51.4%) 6 (46.2%)
 HgbSC 10 (28.6%) 5 (38.5%)
 Others 7 (20.0%) 2 (15.3%)
Hydroxyurea Treatment 8 (22.8%) 4 (30.7%)
Pain Frequency
 None 16 (45.7%) 3 (23.0%)
 1 – 2 / year 15 (42.9%) 7 (53.8%)
 ≥3 / year 4 (11.4%) 3 (23.1%)
Pain (Day of Testing)
 No 21 (60%) 9 (69.0%)
 Yes 14 (40.0%) 4 (30.8%)
  Mean Pain* 2.5 ± 1.9 1.3 ± 0.8
Overall Pain Past Month
 No 13 (37.1%) 5 (38.5%)
 Yes 22 (62.9%) 8 (61.5%)
  Mean Overall Pain* 4.7 ± 2.4 4.3 ± 2.4
Pain Sites**
 Head/Neck 6 (17.1%) 4 (30.8%)
 Chest 6 (17.1%) 3 (23.1%)
 Abdomen 6 (17.0%) 3 (23.1%)
 Low Back 3 (08.6%) 3 (23.1%)
 Upper Extremities (Muscular) 7 (20.0%) 3 (23.1%)
 Lower Extremities (Muscular 9 (25.7%) 2 (15.4%)
 Bones [sternum/femur/tibia/spine] 4 (11.4%) 4 (30.8%)
 Joints [shoulder, elbows, knees, ankles] 6 (17.1%) 2 (15.4%)
*

Mean Pain on 0 to 10 Visual Analog Scale

**

Number of Pain sites on the Body Outline Diagram of the Modified Adolescent Pediatric Pain Tool42,43